Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Eton Pharma (ETON) Earnings Call Transcript
Thursday, March 19, 2026 at 4:30 p.m. ET Chief Executive Officer — Sean E. Brynjelsen Chief Financial Officer — James R. Gruber Chief Commercial Officer — Ipek Erwan Need a quote from a Motley Fool analyst? Email [email…
Natco Pharma's generic Semaglutide set for roll out today
Natco Pharma will launch its Semaglutide injection (multi dose vials) in the domestic market on Saturday. It will be available tomorrow, day 1 of patent expiry, the Hyderabad-based generic drugmaker said on Friday. Semaglutide is the active…
USFDA closes inspection of Apitoria Pharma's facility with VAI
An API manufacturing facility of Apitoria Pharma, a wholly-owned subsidiary of Aurobindo Pharma in Pashamylaram here, has received an establishment inspection report (EIR) from the United States Food and Drug Administration (USFDA). It classified…
Natco Pharma launches generic Semaglutide injection in India
Natco Pharma has launched the Semaglutide injection in India on the first day of its patent expiry. Hyderabad-based Natco received approval from Central Drugs Standard Control Organisation (CDSCO) to manufacture and market generic Semaglutide in…
Iran war has not disrupted pharma supply chains. That could change if conflict is prolonged
The escalating war in the Middle East so far has not appreciably disrupted global pharmaceutical supply chains, but with no clear end in sight, the potential exists for the conflict to change the calculus for production, shipping, and, ultimately…
Stock markets recover on buying in IT, PSU bank stocks
quity benchmark indices Sensex and Nifty gave up most of their intra-day gains to end nearly 0.5 per cent higher on Friday, following intense buying in PSU bank, IT and metal stocks amid concerns over a further spike in fuel-driven inflation. In…
Royalty Pharma PLC $RPRX Stock Position Raised by JPMorgan Chase & Co.
JPMorgan Chase & Co. boosted its holdings in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 28.1% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,759,620 shares…
Royalty Pharma PLC $RPRX Shares Purchased by Tudor Investment Corp ET AL
Tudor Investment Corp ET AL raised its position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 34.4% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 863,835 shares of the biopharmaceutical…
Hudson Bay Capital Management LP Buys New Position in Ascendis Pharma A/S $ASND
Hudson Bay Capital Management LP purchased a new position in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 78,934…
Children's ibuprofen recalled nationwide after customer complaints of 'gel-like mass and black particles
Nearly 90,000 bottles of children's ibuprofen have been recalled across the United States, according to an enforcement report this week from the Food and Drug Administration (FDA). Strides Pharma Inc. has recalled 89,952 bottles of Children's…
Stock markets recover on buying in IT, PSU bank stocks
Indian stock markets rebounded after a significant plunge, with the Sensex and Nifty showing gains amidst volatile trading driven by PSU bank, IT, and metal stocks, but concerns over fuel prices and global tensions persist. Sensex and Nifty rebound…
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a disclosure under Chapter 9, Section 5 of the…
Jim Cramer's top 10 things to watch in the stock market Friday
My top 10 things to watch Friday, March 20 1. Stock futures are down this morning as oil works its way back up after a brief move lower on Thursday. The major averages are pacing for their fourth losing week in a row, with the S & P 500 and Dow…
U.K. to take another look at cost-effectiveness of Alzheimer's drugs
LONDON — U.K. health officials on Friday said they had reopened a review of two new Alzheimer's therapies after previously finding they did not provide good therapeutic value for how much they cost. The two drugs, Eli Lilly's Kisunla and…
Stock markets recover on buying in IT, PSU bank stocks; Sensex climbs 325 points
Equity benchmark indices Sensex and Nifty gave up most of their intra-day gains to end nearly 0.5% higher on Friday (March 20, 2026), following intense buying in PSU bank, IT and metal stocks amid concerns over a further spike in fuel-driven…
Receive a Daily briefing on Pharma Industry News
Get Started